Filing Details

Accession Number:
0001815776-24-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-15 16:13:06
Reporting Period:
2024-05-14
Accepted Time:
2024-05-15 16:13:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1815776 Lenz Therapeutics Inc. LENZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1706176 R. Daniel Chevallard C/O Lenz Therapeutics, Inc.
445 Marine View Ave Suite 320
Del Mar CA 92014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-14 3,188 $15.68 3,188 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct